Intercure Ltd.
INCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857030
No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Intercure Ltd. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 15 | 16 | +1 |
| Shares | 602.9K | 611.5K | +8.62K (+1.4%) |
| Value | $617.9K | $764.1K | +$146.2K (+23.7%) |
New holders (2)
Institutions that held Intercure Ltd. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Atria Investments LLC | 11,957 | $13.2K | 0.00% |
| UBS Group AG | 1,333 | $1.47K | 0.00% |
Sold out (1)
Institutions that held Intercure Ltd. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Advisor Group Holdings, Inc. | 250 | $187 |